VANCOUVER, British Columbia, Jul 13, 2007 -- ProtoKinetix Inc.'s (OTCBB: PKTX) Board of Directors is pleased to announce the appointment of Dr. Julia Hunter to their Business Development Advisory Board. After working exclusively with plastic surgeons as an anaesthesiologist, Dr. Hunter chose to retrain in Dermatology at Doctor's Cosmetic, Laser, Dermatology and Plastic Surgery Center in Annapolis, MD.
Retraining and experience in the dermatology workplace substantiated her approach and treatment protocols for anti-aging, disease prevention and treatment, laser and therapeutic skin care and product usage. Dr. Hunter continued to expand her knowledge of integrative, multi-modality and specialty solutions to create the physiologically correct road map to wellness and skin beauty and health for which she is known.
Julia Hunter, MD is the founder of Skin Fitness Plus in Beverly Hills, California. She has become a well acknowledged authority on anti-aging and skin care in Hollywood. ProtoKinetix believes that Dr. Hunter's extensive experience in these arenas will be of significant value on the development of formulation for the cosmetic and skin care industries. This is the first appointment onto the Business Development Advisory Board to accelerate the commercialization of the family of AAGP(TM) molecules.
About ProtoKinetix:
ProtoKinetix Inc. is a Biotechnical Company that has developed and patented a family of synthetic antifreeze glycoproteins (AAGP(TM)) for human and veterinary medicine, the pharmaceutical and cosmetic industries. Using previously published research on native antifreeze proteins and antifreeze glycoproteins as a guide, and coordinating a vast pool of world recognized intellectual talent in a networked environment, PKTX is currently negotiating commercial and collaborative agreements on several of the proven and tested applications. Sign up for free automatic email news alerts at our new website at: www.protokinetix.com
The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company's filings with the Securities and Exchange Commission.
On behalf of the Board of Directors
Company Office:
Suite # 1500 885 West Georgia Street Vancouver, BC V6C 3E
